FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:476-481 January 29, 2004 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Perspective by Acheson, D. W.K. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A 34-year-old man presented to the emergency department two weeks after returning from a trip to India, reporting a six-day history of anorexia, vomiting, malaise, fatigue, and dark urine. His alanine aminotransferase level was 7330 U per liter, the bilirubin level was 8 mg per deciliter (137 µmol per liter), and a test of the serum for hepatitis A IgM antibodies was . . . [Full Text of this Article]

The Clinical and Public Health Problems

Strategies and Evidence

Hepatitis A Vaccine

Strategies for the Use of Hepatitis A Vaccine

Immune Globulin for Passive Immunoprophylaxis

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Communicable and Environmental Disease Services Section, Tennessee Department of Health (A.S.C.); and the Department of Preventive Medicine, Vanderbilt University School of Medicine (W.S.) — both in Nashville.

Address reprint requests to Dr. Schaffner at the Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, or at william.schaffner@vanderbilt.edu.

Related Letters:

Hepatitis A Vaccine
Van Herck K., Van Damme P., Rosenthal P., Craig A. S., Schaffner W.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:2211-2212, May 20, 2004. Correspondence

This article has been cited by other articles:

• Rein, D. B., Hicks, K. A., Wirth, K. E., Billah, K., Finelli, L., Fiore, A. E., Hoerger, T. J., Bell, B. P., Armstrong, G. L. (2007). Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States. Pediatrics 119: e12-e21 [Abstract] [Full Text]  
• Dagan, R., Leventhal, A., Anis, E., Slater, P., Ashur, Y., Shouval, D. (2005). Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers. JAMA 294: 202-210 [Abstract] [Full Text]  
• Van Herck, K., Van Damme, P., Rosenthal, P., Craig, A. S., Schaffner, W. (2004). Hepatitis A Vaccine. NEJM 350: 2211-2212 [Full Text]